Volastra Therapeutics, Inc.
3 clinical trials · Sponsor
◉ Watch Volastra Therapeutics, Inc.
| Record | Firm | Date |
|---|---|---|
| A Study of Sovilnesib in Subjects With Ovarian Cancer (NCT06084416) | Volastra Therapeutics, Inc. | 2024-04-04 |
| A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer (NCT05902988) | Volastra Therapeutics, Inc. | 2023-10-18 |
| Study of AMG 650 in Adult Participants With Advanced Solid Tumors (NCT04293094) | Volastra Therapeutics, Inc. | 2020-03-11 |
Track Volastra Therapeutics, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.